Search results
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 5 days agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 2 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 2 days agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks via Yahoo Finance· 5 days agoInvestors are always looking for stocks that are poised to beat at earnings season and BioNTech SE...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks· 5 days agoFree Report) may be one such company. In fact, the Most Accurate Estimate for the current quarter is currently pegged at an earnings of 14 cents per share for BNTX, compared to a broader Zacks ...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 2 days agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 6 hours agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
BioNTech Slips To Loss In Q1
RTT News· 2 days agoImmunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 7 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Evonik expects Q2 core profit in line with Q1, confirms 2024 outlook
Reuters via Yahoo Finance· 7 hours agoEvonik's chemicals are used in products from cars to animal feed, as well as in Pfizer and BioNTech's COVID vaccine. ($1 = 0.9311 euros) (Reporting by Anastasiia Kozlova and ...